James Ronald Gillig - Indianapolis IN, US Lawrence Joseph Heinz - Pittsboro IN, US Michael Dean Kinnick - Indianapolis IN, US John Michael Morin - Brownsburg IN, US Nancy June Snyder - Lizton IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31/165 C07C 55/06 C07C 323/42
US Classification:
514618, 562597, 564162
Abstract:
The present invention relates to a melanin concentrating hormone antagonist compound of Formula I: (I) wherein Ar, Ar, Ar, L, Land Q areas defined, or a pharmaceutically acceptable salt, solvate, enantiomer or mixture of diastereomers thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and Related Diseases.
Multicyclic Compounds For Use As Melanin Concentrating Hormone Antagonists In The Treatment Of Obesity And Diabetes
Jochen Ammenn - Hamburg, DE James Ronald Gillig - Indianapolis IN, US Lawrence Joseph Heinz - Pittsboro IN, US Philip Arthur Hipskind - New Palestine IN, US Michael Dean Kinnick - Indianapolis IN, US James Arthur Nixon - Indianapolis IN, US Carsten Ott - Bad Segeberg, DE Kenneth Allen Savin - Indianapolis IN, US Theo Schotten - Vierhoefen, DE Lawrence John Slieker - Carmel IN, US Nancy June Snyder - Lizton IN, US Michael Alan Robertson - Indianapolis IN, US
The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
Cyclohexylimidiazole Lactam Derivatives As Inhibitors Of 11-Β-Hydroxysteroid Dehydrogenase 1
Ashraf Saeed - Westfield IN, US Owen Brendan Wallace - Westfield IN, US Yanping Xu - Noblesville IN, US Thomas Edward Mabry - Indianapolis IN, US Rebecca Lynn Rezac Guenther - Lonsdale MN, US Nancy June Snyder - Lizton IN, US
The present invention discloses novel compounds of Formula I: (I) having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11β-HSD type 1 activity.
Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1
The present invention discloses novel compounds of Formula (I): having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11β-HSD type 1 activity.
Cyclohexyl Substituted Pyrrolidinones As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1
Owen Brendan Wallace - Westfield IN, US Yanping Xu - Noblesville IN, US Nancy June Snyder - Lizton IN, US Jeremy Schulenburg York - Noblesville IN, US Alexei Pavlovych Krasutsky - Zionsville IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31/4015 C07D 207/26
US Classification:
514424, 548543
Abstract:
The present invention discloses novel compounds of Formula I: having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11β-HSD type 1 activity.
Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1
Julie Kay Bush - McCordsville IN, US Marvin Martin Hansen - Indianapolis IN, US Renhua Li - Fishers IN, US Thomas Edward Mabry - Indianapolis IN, US Nancy June Snyder - Lizton IN, US Owen Brendan Wallace - Westfield IN, US Yanping Xu - Noblesville IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 405/00 A61K 31/535 A61K 31/445
US Classification:
546208, 546214, 5142355, 514326
Abstract:
The present invention discloses novel compounds of Formula I: (I) having 11-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11-HSD type 1 activity.
Robin D. G. Cooper - Indianapolis IN Bret E. Huff - Mooresville IN Thalia I. Nicas - Indianapolis IN John T. Quatroche - Indianapolis IN Michael J. Rodriguez - Indianapolis IN Nancy J. Snyder - Charlottesville IN Michael A. Staszak - Indianapolis IN Richard C. Thompson - Frankfort IN Stephen C. Wilkie - Indianapolis IN Mark J. Zweifel - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07K 750 C07K 900 A61K 3702
US Classification:
514 8
Abstract:
The present invention provides glycopeptide antibiotic derivative compounds. These derivative compounds possess antibacterial activity aginst a wide variety of bacteria, including activity against vancomycin-resistant isolates. Methods of making and using these glycopeptide antibiotic derivative compounds are also provided.
Robin David Grey Cooper - Indianapolis IN Michael John Rodriguez - Indianapolis IN Nancy June Snyder - Charlottesville IN Mark James Zweifel - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3812 A61K 3808 C07K 700 C07K 900
US Classification:
514 8
Abstract:
The present invention is directed to amides of antibiotic A82846B (also known as chloroorienticin A), and of N. sup. 4 -derivatives of A82846B. The present amide compounds are useful as antibacterials, especially for the control of gram positive bacteria; the compounds are particularly useful for the control of resistant bacterial strains, such as vancomycin-resistant-enterococci ("VRE").
Isbn (Books And Publications)
Mastering Virtual Teams: Strategies, Tools, and Techniques That Succeed
May 2002 to 2000 Mechanical EngineerNew Leaf United Methodist Church Conneaut, OH Jun 2010 to Jun 2013 Pastor of Care & CounselingAmboy United Methodist Church Conneaut, OH Oct 2001 to Sep 2005 Music Director/Worship LeaderPremix N Kingsville, OH Feb 2001 to Nov 2001 Supervisor, Compound Upper Level TeamPremix N Kingsville, OH Mar 1999 to Feb 2001 Quality Systems Engineer - Compound DivisionPremix N Kingsville, OH Sep 1994 to Mar 1999 Engineer - Compound DivisionKent State University Ashtabula, OH Aug 1997 to Dec 1997 InstructorErie Bearing Company Meadville, PA Jan 1995 to Jun 1995 Inside SalesR&D Laboratory Services
Apr 1989 to Sep 1994 SupervisorPremix, Inc. North Kingsville, OH Jun 1987 to Apr 1989 R&D Research TechnicianErie Bearing Company Meadville, PA Mar 1984 to Nov 1984 Inside SalesGipson Bearing Company Ashtabula, OH Jul 1983 to Feb 1984 Office ManagerGipson Bearing Company Ashtabula, OH Oct 1979 to Jul 1983 Inside Sales
Education:
St. Vincent Charity Medical Center Cleveland, OH Jan 2010 to Jan 2012 4th Unit in Clinical Pastoral EducationNational Institute for Crisis Response Training Lincolnton, NC Jan 2011 to Jan 2011 Pastoral Crisis Intervention I & II; Suicide Prevention/Intervention/PostventionHospice of the Western Reserve Cleveland, OH Jan 2011 to Jan 2011 Spiritual Care Volunteer TrainingAshland Theological Seminary Ashland, OH Jan 2005 to Jan 2010 Master of Divinity in Pastoral CounselingYoungstown State University Youngstown, OH Jan 1988 to Jan 1992 BS in Mechancial Engineering TechnologyKent State University Ashtabula, OH Jan 1984 to Jan 1987 AAS in Mechanical Engineering Technology; Electrical Electronic Engineering Technology
The worst things we are dealing with are the hundreds of trees that we are trying to get off our tracks and overhead wires, said Nancy Snyder, a spokeswoman for New Jersey Transit. Ms. Snyder said that in some places in the western and northern areas of the state, crews had to contend with snow ne
Date: Mar 09, 2018
Category: U.S.
Source: Google
Some NJ Transit train lines still sidelined for evening commute
Pascack Valley Line trains will run on a limited schedule this evening with seven trains operating this evening from Hoboken Terminal, said Nancy Snyder, a spokeswoman. The last PVL train to run from Hoboken Terminal will depart Hoboken at 7:29 p.m., Snyder said.
Date: Mar 08, 2018
Category: Business
Source: Google
Heavy snow, wind force delays on NJ Transit trains
Service on the Morris and Essex lines was suspended due to two overhead wire problems.Gladstone branch was suspended, between Summit and Gladstone, and service on the M&E suspended between Denville and Dover, said Nancy Snyder, an NJ Transit spokeswoman. Crews are responding to both problems.
Date: Mar 07, 2018
Category: Business
Source: Google
NJ Transit announces suspension of all bus service
The suspension means that no buses will depart after 4:30 p.m., but buses already running will continue until they reach their destination, said Nancy Snyder, an NJ Transit spokeswoman. Lakeland Bus Lines also suspended service until Thursday morning.
Date: Mar 07, 2018
Category: Business
Source: Google
NJ Transit adds more rail service to and from NY after collision
The Amtrak Acela train that derailed was still blocking access to tracks 1 through 11 at Penn Station at a junction near the Hudson River tunnels early Friday afternoon, which is causing a major bottleneck, said Nancy Snyder, an NJ Transit spokeswoman. NJ Transit operates about 450 trains each day i
Date: Mar 24, 2017
Source: Google
Service restored on 2 of New Jersey's busiest rail lines
The Northeast Corridor Line and the North Jersey Coast Line have resumed service between Penn Station New York and Trenton and Long Branch in both directions, said Nancy Snyder, an NJ Transit spokeswoman. "Customers will experience significant delays due to restricted speeds through the Linden area.
Date: Jan 23, 2017
Category: Business
Source: Google
NJ Transit gets off to a cold start with 45-minute delays
train with 45 people on board became disabled near the the Jersey Avenue station around 5 a.m., according to NJ Transit spokeswoman Nancy Snyder, who said that the heating system on board remained on during that time. Snyder said another train was immediately dispatched to pick up those passengers.
Date: Jan 09, 2017
Category: U.S.
Source: Google
Will Secaucus, Hoboken stations be ghost towns if one-seat loop is built?
Secaucus Junction is NJ Transit's fourth-busiest station, according to the agency.Ridership therehas steadily increased from 20,649 trips in fiscal year 2012 to 27,568 trips in fiscal year 2016, said Nancy Snyder, an NJ Transit spokeswoman. Hoboken is the fifth busiest, with15,101 trips in fiscal
Date: Oct 21, 2016
Category: Business
Source: Google
Youtube
Will Vic Snyder Support Nancy Pelosi's Govern...
Category:
News & Politics
Uploaded:
19 Aug, 2009
Duration:
26s
Great, Great Joy! W/DWFB Jazz Band & Guest Vo...
Guess vocalist Alan Scott-Bass; Linsay Karg-Tenor; Laura Stave-Alto & ...
Category:
Travel & Events
Uploaded:
20 Dec, 2008
Duration:
3m 29s
Nancy Snyder and Lovely Lucy
Nancy and Lucy racing
Category:
People & Blogs
Uploaded:
05 Dec, 2010
Duration:
31s
Tom Ring Congratulates Gerry and Nancy Snyder...
"Eric is a definite assest for you to have an an employee. He was very...
Self Employed - Internet Marketing (2008) Marriott Vacation Club International - Master Sales Executive (2001-2008) Westgate Lakes Resort - Timeshare Sales Person (2001-2001) Time to Travel - Owner / Agent (1997-2001) World Travel Partners - Manager of Group & Convention Department (1990-1997) Inn Tours World Travel - Corporate Travel Agent & Group Travel Coordinator (1986-1990) Preferred Travel - Corporate Travel Consultant (1999-2001)